Published in AIDS Weekly, June 2nd, 2008
"A total of 5,472 patients with CD4(+) T-cell counts >350 cells/mm(3) were recruited and randomized to either continuous ART (the viral suppression arm; VS) or CD4(+) T-cell count-guided use of ART (the drug conservation arm; DC). Major CVD events developed in 79 patients. The hazard ratio (HR) for risk of CVD events for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.